CD4 and neoplasm: The tumor microenvironment (TME), which is primarily composed of tumor-infiltrating immune cells (TIICs), such as neutrophils, CD4+ helper T cells, CD8+ cytotoxic T cells, NK cells, and macrophages, has been identified as a critical factor influencing the progression and treatment of HCC [22,23].